HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shiguang Ye Selected Research

Immunoglobulin Isotypes

11/2022Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shiguang Ye Research Topics

Disease

2Neoplasms (Cancer)
01/2021 - 03/2016
2Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020 - 12/2020
1Multiple Myeloma
11/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Infections
01/2021
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2020
1Leukemia
03/2016
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2016
1Myeloid Leukemia (Leukemia, Myelocytic)
03/2016
1Carcinogenesis
03/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2015

Drug/Important Bio-Agent (IBA)

3Chimeric Antigen ReceptorsIBA
01/2021 - 12/2020
2DNA (Deoxyribonucleic Acid)IBA
03/2016 - 12/2015
2Sirtuin 1IBA
03/2016 - 12/2015
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
11/2022
1Immunoglobulin IsotypesIBA
11/2022
1Antiviral Agents (Antivirals)IBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
03/2016
1Small Interfering RNA (siRNA)IBA
03/2016

Therapy/Procedure

3Therapeutics
01/2021 - 12/2020
2Drug Therapy (Chemotherapy)
03/2016 - 12/2015
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1Immunotherapy
12/2020